We next used MCP-counter, a method of inferring immune cell populations from bulk tumor RNAseq (Becht et al. 2016), to determine whether cohorts expressing high or low levels of PER1 mRNA or PER1 protein had altered abundance of any immune cell types. Here, PER1 is linked to neoplasm.